当前位置:首页 - 行情中心 - 迈瑞医疗(300760) - 财务分析 - 现金流量表

迈瑞医疗

(300760)

  

流通市值:2868.10亿  总市值:2868.15亿
流通股本:12.12亿   总股本:12.12亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金8,732,237,37440,142,581,62931,577,572,78821,802,433,530
  收到的税费返还250,579,8071,005,531,131866,820,743499,940,673
  收到其他与经营活动有关的现金453,341,538800,729,404616,673,890448,100,871
  经营活动现金流入小计9,436,158,71941,948,842,16433,061,067,42122,750,475,074
  购买商品、接受劳务支付的现金3,146,581,72014,685,533,87510,379,652,5376,329,579,604
  支付给职工以及为职工支付的现金3,400,100,5688,118,905,8906,428,507,7994,646,525,262
  支付的各项税费752,899,7424,298,552,1473,297,688,7012,000,500,686
  支付其他与经营活动有关的现金642,168,6322,413,808,9711,882,337,3881,278,074,566
  经营活动现金流出小计7,941,750,66229,516,800,88321,988,186,42514,254,680,118
  经营活动产生的现金流量净额1,494,408,05712,432,041,28111,072,880,9968,495,794,956
二、投资活动产生的现金流量:
  收回投资收到的现金744,600,0001,323,911,149592,800,000183,000,000
  取得投资收益收到的现金1,566,2785,360,9012,799,0411,138,654
  处置固定资产、无形资产和其他长期资产收回的现金净额2,876,37930,736,11514,757,1346,948,606
  收到的其他与投资活动有关的现金-141,535,123141,245,072-
  投资活动现金流入小计749,042,6571,501,543,288751,601,247191,087,260
  购建固定资产、无形资产和其他长期资产支付的现金497,382,5771,959,448,2541,417,824,137910,971,335
  投资支付的现金685,000,0001,112,301,559730,696,848149,196,848
  取得子公司及其他营业单位支付的现金-5,773,292,2745,773,292,2745,721,410,094
  支付其他与投资活动有关的现金-39,712,00039,712,00039,712,000
  投资活动现金流出小计1,182,382,5778,884,754,0877,961,525,2596,821,290,277
  投资活动产生的现金流量净额-433,339,920-7,383,210,799-7,209,924,012-6,630,203,017
三、筹资活动产生的现金流量:
  吸收投资收到的现金-78,533,52469,759,00569,759,005
  其中:子公司吸收少数股东投资收到的现金-78,533,52469,759,00569,759,005
  取得借款收到的现金52,0722,643,4102,412,327-
  收到其他与筹资活动有关的现金-50,545,87538,036,32737,954,968
  筹资活动现金流入小计52,072131,722,809110,207,659107,713,973
  偿还债务支付的现金685,9225,500,3585,112,2574,709,303
  分配股利、利润或偿付利息支付的现金161,3728,843,406,8466,842,338,5281,819,173,541
  其中:子公司支付给少数股东的股利、利润-100,905,212100,905,212-
  支付其他与筹资活动有关的现金29,455,976164,529,004121,538,57873,384,297
  筹资活动现金流出小计30,303,2709,013,436,2086,968,989,3631,897,267,141
  筹资活动产生的现金流量净额-30,251,198-8,881,713,399-6,858,781,704-1,789,553,168
四、汇率变动对现金及现金等价物的影响16,298,89972,189,446-89,628,68122,076,855
五、现金及现金等价物净增加额1,047,115,838-3,760,693,471-3,085,453,40198,115,626
  加:期初现金及现金等价物余额14,907,725,80718,668,419,27818,668,419,27818,668,419,278
  期末现金及现金等价物余额15,954,841,64514,907,725,80715,582,965,87718,766,534,904
补充资料:
  净利润-11,739,966,642-7,575,938,532
  资产减值准备-237,841,474-225,471,335
  固定资产和投资性房地产折旧-625,926,899-293,311,861
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-624,042,336-293,311,861
    投资性房地产折旧-1,884,563--
  无形资产摊销-712,662,325-298,881,066
  长期待摊费用摊销-34,417,151-16,581,484
  递延收益摊销--37,903,465--
  处置固定资产、无形资产和其他长期资产的损失--4,243,844--3,540,498
  公允价值变动损失--126,027,776--126,284,421
  财务费用-97,399,220--12,100,947
  投资损失--69,390,139--63,439,016
  递延所得税--440,236,450-26,142,238
  其中:递延所得税资产减少--373,672,224-45,970,363
    递延所得税负债增加--66,564,226--19,828,125
  存货的减少--782,046,572--238,898,934
  经营性应收项目的减少--347,146,870--916,572,922
  经营性应付项目的增加-402,206,123-1,252,291,820
  其他---106,575,737
  不涉及现金收支的投资和筹资活动金额其他项目-79,576,430--
  现金的期末余额-14,907,725,807-18,766,534,904
  减:现金的期初余额-18,668,419,278-18,668,419,278
  现金及现金等价物的净增加额--3,760,693,471-98,115,626
公告日期2025-04-292025-04-292024-10-302024-08-30
审计意见(境内)标准无保留意见
TOP↑